JOMED NV
JOMED NV
Status:
Active
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2002-07-01 | Transvascular | Jomed NV investment in Series D - Transvascular | 10.8 M USD |
More informations about "Jomed NV"
JOMED NV - Drug pipelines, Patents, Clinical trials - Synapse
Explore JOMED NV with its drug pipeline, therapeutic area, technology platform, 1 news, and 6 literature. Explore JOMED NV with its drug pipeline, therapeutic area, technology platform, 1 โฆSee details»
Jomed NV - Investments, Portfolio & Company Exits - Crunchbase
Jomed NV has invested in Transvascular on Jul 1, 2002. This investment - Series D - Transvascular - was valued at . obfuscated. obfuscated. Jomed NV has had . obfuscated. โฆSee details»
Jomed NV /The Coronary & Peripheral Interventional Business/
Explore Jomed NV /The Coronary & Peripheral Interventional Business/ with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
JOMED Portfolio Investments, JOMED Funds, JOMED Exits - CB โฆ
JOMED is a medical technology company based in Switzerland. Use the CB Insights Platform to explore JOMED's full profile.See details»
The final blow? Jomed goes bankrupt - insights.citeline.com
Jomed NV, the Netherlands-based parent of operating companies in various countries including Germany and the US, has been declared bankrupt. However, the bankruptcy does not include โฆSee details»
Abbott signs asset purchase agreement for Jomed's coronary and ...
The addition of Jomed's stent graft, balloon and catheter devices adds new technologies to Abbott's vascular product offerings. Stent grafts are used in acute situations such as โฆSee details»
Jomed NV Asset Profile | Preqin
Jomed NV is based in Netherlands and engage in development, production, sale, and the distribution of cardiovascular devices. Primary Industry Medical Devices & Equipment Sub โฆSee details»
Jomed NV /Percutaneous Mitral Valve Repair Program/
Last update 05 Sep 2024. Jomed NV /Percutaneous Mitral Valve Repair Program/ Private Company |See details»
JOMED NV:Company Profile & Technical Research,Competitor โฆ
JOMED NV is headquartered in NL LI. JOMED NV was founded in 1991. JOMED NV has a total of 67 patents . Related Topics. Medicine Medical equipment Dental Equipment. Login to view โฆSee details»
JOMED NV:Investment,Investment Series,Investment Analysis
Discovery Company profile page for JOMED NV including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
JOMED NV (JOMED NV) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅๆถ
May 1, 2023 ้กนไธ jomed nv ็ธๅ ณ็ๆ็ฎ๏ผๅป่ฏ๏ผ 2000-08-01 · The Journal of the Acoustical Society of America 3ๅบ · ็ฉ็ไธๅคฉไฝ็ฉ็ Simulation of circular array ultrasound transducers โฆSee details»
Jomed NV - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Jomed NV - Tech Stack, Apps, Patents & Trademarks - Crunchbase ... Jomed NVSee details»
Jomed Group (Coronary And Peripheral Business) - PitchBook
Jomed Group (Coronary And Peripheral Business) General Information Description. Operator of coronary and peripheral interventional business.The company's coronary and peripheral โฆSee details»
Abbott buys Jomed vascular interventional products - Scrip
May 30, 2003 Bankrupt Swiss-Dutch MIS vascular specialist Jomed has raised some E80m ($95m) through the sale of a part of its business to a subsidiary of Abbott Laboratories. E60m โฆSee details»
Jomed N.V. - US Patent and Trademark Search
JOMED NV of NETHERLANDS: uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark โฆSee details»
End of the Line for Jomed? - mddionline.com
Jul 1, 2003 Jomed got off to a great start in 2003, and was widely hailed as Europe's leading manufacturer of minimally invasive vascular intervention products. However, things quickly โฆSee details»
JOMED NV:Acquisition,Acquisition Analysis & Reports - Discovery
Discovery Company profile page for JOMED NV including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
JOMED continues rapid growth - Pharmaceutical industry news
Feb 12, 1999 JOMED continues rapid growth 12 February 1999 Swedish firm JOMED, a leading European developer and manufacturer ofproducts for minimally-invasive intervention and โฆSee details»